Schott Pharma publishes August 2026 business factsheet

Reuters2026/08/12 05:14

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Schott Pharma published an August 2026 business factsheet covering FY 2025 results.
Revenue EUR 986 million; EBITDA EUR 280 million; EBITDA margin 28.4%.
Global footprint spans 17 production facilities, including four joint ventures, across 15 countries.
R&D portfolio includes more than 1,300 filed IP rights; 125 R&D employees.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Schott Pharma AG & Co. KGaA published the original content used to generate this news brief on August 12, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Schott Pharma publishes August 2026 business factsheet

You may also like

Crypto prices